Habituation to pain in "medication overuse headache": A CO 2 laser-evoked potential study

Headache

Volumn 52, Issue 5, 2012, Pages 792-807

  Ferraro, Diana ^a,e   Vollono, Catello ^b   Miliucci, Roberto ^b   Virdis, Daniela ^a   De Armas, Liala ^c   Pazzaglia, Costanza ^a   Le Pera, Domenica ^c   Tarantino, Samuela ^b   Balestri, Martina ^b   Di Trapani, Girolamo ^a   Valeriani, Massimiliano ^b,d  

^a CATHOLIC UNIVERSITY   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d AALBORG UNIVERSITY   (Denmark)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

habituation; laser evoked potential; medication overuse headache; migraine

Indexed keywords

AMITRIPTYLINE; BUTALBITAL; CAFFEINE; CINNARIZINE; DEXAMETHASONE; ELETRIPTAN; ETIRACETAM; FLUNARIZINE; GABAPENTIN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROCHLORPERAZINE; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

ADULT; AGED; ARTICLE; CARBON DIOXIDE LASER; CLINICAL ARTICLE; DEPRESSION; DRUG INDUCED HEADACHE; EPISODIC MIGRAINE; EVOKED SOMATOSENSORY RESPONSE; FACE; FEMALE; HABITUATION; HAND; HUMAN; MALE; NOCICEPTIVE STIMULATION; PRIORITY JOURNAL;

ADULT; AGED; ANALYSIS OF VARIANCE; EVOKED POTENTIALS; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; HEADACHE DISORDERS; HUMANS; LASERS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PSYCHOPHYSICS; REACTION TIME; SUBSTANCE-RELATED DISORDERS;

EID: 84860739587     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02151.x     Document Type: Article

References (48)

1. Olesen J, Bousser MG, Diener HC, et al,. Headache Classification Committee: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006; 26: 742-746.
2. Evers S, Marziniak M,. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010; 9: 391-401.
3. Bromm B, Treede RD,. Nerve fibre discharges, cerebral potentials and sensations induced by CO2 laser stimulation. Hum Neurobiol. 1984; 3: 33-40. (Pubitemid 14079284)
4. Garcia-Larrea L, Frot M, Valeriani M,. Brain generators of laser-evoked potentials: From dipoles to functional significance. Neurophysiol Clin. 2003; 33: 279-292. (Pubitemid 38044021)
5. Valeriani M,. Are CO2 laser evoked potentials a specific marker of migraine? Funct Neurol. 2005; 20: 201-207.
6. De Tommaso M, Baumgartner U, Sardaro M, Difruscolo O, Serpino C, Treede RD,. Effects of distraction versus spatial discrimination on laser-evoked potentials in migraine. Headache. 2008; 48: 408-416. (Pubitemid 351517780)
7. de Tommaso M, Giuseppe L, Guido M, Losito L, Lamberti P, Livrea P,. Habituation of single CO2 laser-evoked responses during interictal phase of migraine. J Headache Pain. 2005; 6: 195-198. (Pubitemid 41349301)
8. de Tommaso M, Guido M, Libro G, et al,. Topographic and dipolar analysis of laser evoked potentials during migraine attack. Headache. 2004; 44: 947-960. (Pubitemid 39532336)
9. de Tommaso M, Guido M, Libro G, et al,. Abnormal brain processing of cutaneous pain in migraine patients during the attack. Neurosci Lett. 2002; 333: 29-32. (Pubitemid 35223595)
10. de Tommaso M, Lo Sito L, Di Fruscolo O, et al,. Lack of habituation of nociceptive evoked responses and pain sensitivity during migraine attack. Clin Neurophysiol. 2005; 116: 1254-1264. (Pubitemid 40839333)
11. de Tommaso M, Losito L, Libro G, et al,. Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack. Cephalalgia. 2005; 25: 359-368. (Pubitemid 40559418)
12. Valeriani M, de Tommaso M, Restuccia D, et al,. Reduced habituation to experimental pain in migraine patients: A CO2 laser evoked potential study. Pain. 2003; 105: 57-64. (Pubitemid 37162473)
13. de Tommaso M, Valeriani M, Guido M, et al,. Abnormal brain processing of cutaneous pain in patients with chronic migraine. Pain. 2003; 101: 25-32. (Pubitemid 36044651)
14. Ambrosini A, Schoenen J,. Electrophysiological response patterns of primary sensory cortices in migraine. J Headache Pain. 2006; 7: 377-388. (Pubitemid 46085241)
15. May A,. Chronic pain may change the structure of the brain. Pain. 2008; 137: 7-15.
16. Valeriani M, Rambaud L, Mauguière F,. Scalp topography and dipolar source modelling of potentials evoked by CO2 laser stimulation of the hand. Electroenceph Clin Neurophysiol. 1996; 100: 343-353.
17. 2 laser skin stimulation of the hand and foot in the human brain. Clin Neurophysiol. 2000; 111: 1103-1112. (Pubitemid 30316350)
18. Vogel H, Port JD, Lenz FA, Solaiyappan M, Krauss G, Treede R-D,. Dipole source analysis of laser-evoked subdural potentials recorded from parasylvian cortex in humans. J Neurophysiol. 2003; 89: 3051-3060. (Pubitemid 36682657)
19. Kunde V, Treede RD,. Topography of middle-latency somatosensory evoked potentials following painful laser stimuli and non-painful electrical stimuli. Electroencephalogr Clin Neurophysiol. 1993; 88: 280-289. (Pubitemid 23217856)
20. Treede R-D, Lorenz J, Baumgartner U,. Clinical usefulness of laser-evoked potentials. Neurophysiol Clin. 2003; 33: 303-314. (Pubitemid 38044023)
21. Valeriani M, Sestito A, Le Pera D, et al,. Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J. 2005; 26: 975-982. (Pubitemid 40695028)
22. de Tommaso M, Federici A, Santostasi R, et al,. Laser-evoked potentials habituation in fibromyalgia. J Pain. 2011; 12: 116-124.
23. Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J,. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology. 2004; 62: 1540-1544. (Pubitemid 38608192)
24. Bowdler I, Kilian J,. The association between analgesic abuse and headache-Coincidental or causal. Headache. 1988; 28: 494.
25. Lance F, Parkes C, Wilkinson M,. Does analgesic abuse cause headaches de novo? Headache. 1988; 1: 61-62. (Pubitemid 18089808)
26. Burstein R,. Deconstructing migraine headache into peripheral and central sensitization. Pain. 2001; 89: 107-110. (Pubitemid 32146388)
27. Bigal ME, Lipton RB,. Modifiable risk factors for migraine progression. Headache. 2006; 46: 1334-1343. (Pubitemid 44556426)
28. Scher AI, Stewart WF, Ricci JA, Lipton RB,. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003; 106: 81-89. (Pubitemid 37329617)
29. Sarchielli P, Alberti A, Floridi A, Gallai V,. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology. 2001; 57: 132-134. (Pubitemid 32634864)
30. Sarchielli P, Greco L, Floridi A, Floridi A, Gallai V,. Excitatory amino acids and multiple sclerosis: Evidence from cerebrospinal fluid. Arch Neurol. 2003; 60: 1082-1088. (Pubitemid 36975795)
31. Rossi C, Pini LA, Cupini ML, Calabresi P, Sarchielli P,. Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: Relation with serotonin levels. Eur J Clin Pharmacol. 2008; 64: 1-8.
32. Srikiatkhachorn A, Anthony M,. Serotonin receptor adaptation in patients with analgesic-induced headache. Cephalalgia. 1996; 16: 419-422. (Pubitemid 26338472)
33. Dobson CF, Tohyama Y, Diksic M, Hamel E,. Effects of acute or chronic administration of antimigraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia. 2004; 24: 2-11. (Pubitemid 38085187)
34. Srikiatkhachorn A, Tarasub N, Govitrapong P,. Effect of chronic analgesic exposure on the central serotonin system: A possible mechanism of analgesic abuse headache. Headache. 2000; 40: 343-450.
35. Supornsilpchai W, le Grand SM, Srikiatkhachorn A,. Involvement of pro nociceptive 5-HT(2A) receptor in the pathogenesis of medication-overuse headache. Headache. 2010; 50: 185-197.
36. Welch KMA, Nagesh V, Aurora SK, Gelman N,. Periacqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache. 2001; 41: 629-637. (Pubitemid 32777745)
37. Ayzenberg I, Obermann M, Nyhuis P, et al,. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Pain. 2005; 118: 137-144.
38. Perrotta A, Serrao M, Sandrini G, et al,. Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalalgia. 2010; 30: 272-284.
39. Coppola G, Currà A, Di Lorenzo C, et al,. Abnormal cortical responses to somatosensory stimulation in medication overuse headache. BMC Neurol. 2010; 30: 126.
40. Janicki P, Libich J, Gumulka W,. Lack of habituation of pain evoked potentials after naloxone. Pol J Pharmacol Pharm. 1979; 31: 201-205. (Pubitemid 9249128)
41. Rennefeld C, Wiech K, Schoell ED, Lorenz J, Bingel U,. Habituation to pain: Further support for a central component. Pain. 2010; 148: 503-508.
42. Bingel U, Schoell E, Herken W, Buchel C, May A,. Habituation to painful stimulation involves the antinociceptive system. Pain. 2007; 131: 21-30. (Pubitemid 47187879)
43. Petrovic P, Kalso E, Petersson KM, Ingvar M,. Placebo and opioid analgesia imaging a shared neuronal network. Science. 2002; 295: 1737-1740. (Pubitemid 34202913)
44. Fumal A, Laureys S, Di Clemente L, et al,. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006; 129: 543-550. (Pubitemid 43164376)
45. Currà A, Coppola G, Gorini M, et al,. Drug-induced changes in cortical inhibition in medication overuse headache. Cephalalgia. 2011; 3: 1282-1290.
46. Afra J, Sándor PS, Schoenen J,. Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack. Cephalalgia. 2000; 20: 714-719. (Pubitemid 32127839)
47. Evers S, Jensen R,; European Federation of Neurological Societies. Treatment of medication overuse headache-Guideline of the EFNS headache panel. Eur J Neurol. 2011; 18: 1115-1121.
48. Truini A, Panuccio G, Galeotti F, et al,. Laser-evoked potentials as a tool for assessing the efficacy of antinociceptive drugs. Eur J Pain. 2010; 14: 222-225.